Table 4.

MROAS at T1 in IP and HLCT patients.

	IP	HLCT	Effect size (r or Cramer's V)
MROAS scales
Eating difficulties	3.00 [3.00–4.00]	2.00 [2.00–2.5]***	0.730
Menstrual state	4a	4.00 [4.00–4.00]	0.263
Mental state	4.00 [4.00–4.00]	3.00 [2.00–4.00]*	0.437
Insight	3.00 [3.00–4.00]	2.00 [1.00–2.00]***	0.635
Intimate relationships	4.00 [3.00–4.00]	2.50 [2.00–3.00]**	0.523
Family relationships	3.00 [3.00–3.00]	3.00 [2.00–3.00]	0.230
Social contacts	3.00 [3.00–4.00]	2.50 [2.00–3.00]**	0.509
Occupation	3.00 [3.00–3.00]	2.00 [2.00–2.00]***	0.687
Additive behaviors	1a	1a	0.000
MROAS groups
Good	0 (0.0)	3 (17.6)**	0.592
Intermediate	2 (11.8)	8 (47.1)
Poor	15 (88.2)	5 (29.4)

Data are presented as number and percentage in parentheses (%) for categorical variables, or median and interquartile range in square brackets [IQR] for continuous variables. HLCT, high-level care treatment; MROAS, Morgan–Russel Outcome Assessment Scale; IP, inpatient care. Mann–Whitney and Chi-square tests were used to compare continuous and categorical variables between groups, respectively.

^aConstant values. Statistical significance for p < 0.05.

^*p < 0.05,

^**p < 0.01,

^***p < 0.001. Effect size (r or Cramer's V) was calculated for the Mann–Whitney test or the Chi-square test, respectively. Small, medium, and large effects for r < 0.3, 0.3 ≤ r < 0.5 and r ≥ 0.5, respectively.